Clinical Trials Logo

Pleural Effusions clinical trials

View clinical trials related to Pleural Effusions.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02208895 Completed - Pleural Effusions Clinical Trials

iSTAT Comparison Study, IRB3785

Start date: February 2014
Phase:
Study type: Observational

Pleural fluid glucose levels measured with bed-side point of care methods such as finger stick glucometers and I-STAT device correlate with the traditional in-lab testing methods.

NCT ID: NCT01374542 Completed - Clinical trials for Respiratory Tract Infections

Respiratory Endoscopy: Diagnostic Yield, Technical Factors and Complications

Start date: June 2011
Phase:
Study type: Observational

Background: Respiratory endoscopy comprises flexible bronchoscopy and medical thoracoscopy. The diagnostic yield, technical factors and complications for all patient sub-populations is still not clearly defined. This may result in inappropriate or even dangerous application of such procedures. The aim of the study is to collect data on these aspects of respiratory endoscopy and identify important trends, as well as, areas for improvement. This data will also provide baseline comparative data for new bronchoscopic techniques such as endobronchial ultrasound and navigational bronchoscopy. Method: Prospective data collection. Technical details regarding these procedures are currently keyed into the OTM system by the endoscopy operators for documentation and billing. The department of Respiratory and Critical Care Medicine gets monthly downloads of all the fields from the OTM system for audit purposes.(See data collection form) The research project proposes to make the data non identifiable by removing the patient's name and IC number. Additionally the yield of the procedure will be checked by a chart review of the histology and microbiology results. There are no restrictions on patient recruitment because all procedures will be performed for clinical indications only and no patient will be recruited for the sole purpose of the study. Waiver of consent has been approved by the IRB.

NCT ID: NCT00005906 Completed - Ascites Clinical Trials

Treatment With Octreotide in Patients With Lymphangioleiomyomatosis

Start date: June 2000
Phase: Phase 2
Study type: Interventional

Lymphangioleiomyomatosis (LAM), a disease primarily of women of child-bearing age, is characterized by cystic lung disease and abdominal tumors (e.g., angiomyolipomas). Within the LAM patient population is a subset of patients who develop chylous effusions and lymphangioleiomyomas. Treatment of many of these symptoms has been ineffective. Previous studies with somatostatin and octreotide in other clinical settings have shown reduction in chylous effusions. This study assesses the effectiveness of octreotide in symptomatic patients with LAM, lymphangioleiomyomas and/or chylous effusions/ascites, peripheral lymphedema and chyluria.